Global IVD Companies Issue Fourth Quarter 2024 Earnings

By Robert Michel | From the Volume XXXII, No. 5 – March 31, 2025 Issue

OVERALL, IN VITRO DIAGNOSTICS (IVD) COMPANIES REPORTED A MIXED BAG of financial results for the quarter ending Dec. 31, 2024, with Becton, Dickinson and Company, Abbott Laboratories, and Siemens Healthineers showing the most momentum based on r…

Read More

---

Optum Adds Gestalt to Its Digital Diagnostic Suite

By Robert Michel | From the Volume XXXII, No. 3 – February 17, 2025 Issue

CEO SUMMARY: This development signals Optum’s intent to be a player in digital pathology. Its deal with Gestalt Diagnostics adds a pathology solution to Optum’s existing suite of cloud-based services for managing digital images generated by cardiology, radiology, and hematology-oncolo…

Read More

---

Market Speaks to Pathologists: It’s About Data

By R. Lewis Dark | From the Volume XXXII, No. 3 – February 17, 2025 Issue

ONE PRIMARY TREND IN THE U.S. HEALTHCARE SYSTEM over the past 20 years deals with how patient data is created and used. Ongoing advances in information technology and the Internet—now commonly called “the cloud”—have created capabilities for data sharing and data analysis today that were unim…

Read More

---

Optum Adds Gestalt to Its Digital Diagnostic Suite

By Robert Michel | From the Volume XXXII, No. 3 – February 17, 2025 Issue

CEO SUMMARY: This development signals Optum’s intent to be a player in digital pathology. Its deal with Gestalt Diagnostics adds a pathology solution to Optum’s existing suite of cloud-based services for managing digital images generated by cardiology, radiology, and hematology-oncolo…

Read More

---

December 16, 2024, Intelligence Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 17 – December 16, 2024 Issue

Sonic Healthcare Ltd of Sydney, Australia, announced the acquisition of clinical laboratory company LADR (Laboratory Group Dr. Kramer & Colleagues) based in Geesthacht, Germany, on Dec. 9, 2024. The enterprise value of the deal is €423 million (US$446.9 million…

Read More

---

Global IVD Companies Issue Third Quarter 2024 Earnings

By Robert Michel | From the Volume XXXI, No. 16 – November 25, 2024 Issue

HERE IS A SUMMARY OF THE THIRD QUARTER FINANCIAL PERFORMANCE of t…

Read More

---

October 14, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 14 – October 14, 2024 Issue

Babson Diagnostics of Austin, Texas, received a “strategic investment” from Becton, Dickinson and Company (BD). The amount of the investment was not disclosed. In the past year, Babson launched an innovative lab testing service with retail pharmacies in Austin an…

Read More

---

Global IVD Companies Report Second Quarter 2024 Earnings

By Robert Michel | From the Volume XXXI, No. 13 – September 23, 2024 Issue

IN THE SECOND QUARTER OF 2024, in vitro diagnostics (IVD) companies reported solid revenues as well as new tests, analyzers, and automation. Most of the IVD companies boosted diagnostic sales in low single digit amounts. During the earnings calls, financial analysts asked company leade…

Read More

---

2023 Ranking of the World’s Top 13 IVD Corporations

By Robert Michel | From the Volume XXXI, No. 10 – July 22, 2024 Issue

BASED ON 2023 DIAGNOSTICS-RELATED REVENUE, four in vitro diagnostics (IVD) manufacturers continued to lead the global IVD market just as they did in 2022. They are: Thermo Fisher Scientific, Inc., Roche Holdings, Abbott Laboratories, and Danaher Corporation. Th…

Read More

---

Global IVD Companies Report First Quarter 2024 Earnings

By Robert Michel | From the Volume XXXI, No. 9 – July 1, 2024 Issue

IN THEIR INITIAL FINANCIAL REPORTING F…

Read More

---